Sandoz contributes to fighting the number one cause of death globally
September 29, 2014 – Today is World Heart Day. Cardiovascular disease (CVD) is a global burden accounting for 17.3 million deaths a year - significantly more than all deaths related to malaria, HIV and tuberculosis. By 2030, the World Health Organization estimates more than 23 million people annually will die of CVD.
Due to the prevalence of CVD globally, affordable medicines are a top concern for governments and health authorities. Sandoz has a broad portfolio of generic cardiovascular medications which prevent cardiovascular diseases by lowering lipid levels and reducing high blood pressure. Generic medicines provide health authorities, governments, and patients with affordable, quality alternatives to the originator, or “brand” medicines. Affordable generics are especially needed in countries where patients have to pay out-of-pocket for medicines.